Strides made, but industry held back by challenges that pose risk to investors
A medical worker inspects a CT scan image at a hospital in China in 2020. Currently, most of the approved nuclear medicine drugs in the country are for diagnostic use. (China Daily via Reuters)
WEN SIMIN, Caixin
December 6, 2025 15:30 JST
Often tucked in out-of-the way corners of Chinese hospitals, nuclear medicine departments have for much of their history been mysterious places where few knew exactly what they do there.